Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Valerio Therapeutics clinical trials
Also known as Onxeo, BioAlliance.
The registry lists 27 studies whose lead sponsor is Valerio Therapeutics or one of 2 companies grouped under it. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Mar 17, 2025.
Registry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Valerio Therapeutics.
Studies
Recruiting first, then most recently updated. Showing 27 of 27.
- A Phase 1/2 Study of VIO-01 in Participants With Recurrent Solid TumorsTerminatedNCT06257758Phase 1/2
- Study to Assess Safety and Efficacy of AsiDNA in Combination with Olaparib in Participants with Recurrent Solid TumorsCompletedNCT05700669Phase 1/2
- AsiDNA (a DNA Repair Inhibitor) Administered IntraVenously in Advanced Solid TumorsCompletedNCT03579628Phase 1
- Safety of Intranodal ECI-006 in Melanoma PatientsTerminatedNCT03394937Phase 1
Sponsor listed in the registry: eTheRNA immunotherapies · eTheRNA immunotherapies — acquired company within the Valerio Therapeutics group
- Efficacy and Safety Doxorubicin Transdrug Study in Patients Suffering From Advanced Hepatocellular CarcinomaCompletedNCT01655693Phase 3
- Efficacy and Safety Study of Clonidine Lauriad® to Treat Oral MucositisCompletedNCT01385748Phase 2
- DNA Repair Inhibitor & Irradiation on MelanomaCompletedNCT01469455Phase 1
Sponsor listed in the registry: DNA Therapeutics · First submitted before DNA Therapeutics became part of Valerio Therapeutics
- Phase 1 PK, Bioavailability, Safety Study of Clonidine MBT w Catapres in Healthy VolunteersCompletedNCT02548806Phase 1
- A Clinical Trial on Topotect® (Dexrazoxane) in the Treatment of Accidental Extravasation of AnthracyclinesCompletedNCT00548704Phase 2/3
- Efficacy of TopotectTM (Dexrazoxane) for Accidental Extravasation of AnthracyclinesCompletedNCT00548561Phase 2/3
- A Study to Assess APO866 for the Treatment of Advanced MelanomaCompletedNCT00432107Phase 2
- A Phase I/II Study to Assess the Safety and Tolerability of APO866 for the Treatment of Refractory B-CLLCompletedNCT00435084Phase 1/2
- A Phase I Dose Finding Study of APO010 in Patients With Solid TumorsCompletedNCT00437736Phase 1
- Safety and Efficacy Study of Electrotransfer of Plasmid AMEP to Treat Advanced or Metastatic MelanomaTerminatedNCT01045915Phase 1
- Safety and Efficacy of Intramuscular Electrotransfer of Plasmid AMEP in Patients Suffering From Advanced or Metastatic MelanomaWithdrawnNCT01764009Phase 1/2
- A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse TreatmentCompletedNCT00421889Phase 1/2
- Trial of PXD101 (Belinostat) in Combination With Idarubicin to Treat AML Not Suitable for Standard Intensive TherapyCompletedNCT00878722Phase 1/2
- Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown PrimaryCompletedNCT00873119Phase 2
- A Phase I/II Clinical Trial of PXD101 in Combination With Doxorubicin in Patients With Soft Tissue SarcomasCompletedNCT00878800Phase 1/2
- A Phase II Clinical Trial of PXD101 in Patients With Recurrent or Refractory Cutaneous and Peripheral T-Cell LymphomasTerminatedNCT00274651Phase 2
- A Phase II Study of Belinostat in Combination With Bortezomib in Patients With Relapsed, Refractory Multiple MyelomaTerminatedNCT00431340Phase 2
- A Study of APO866 for the Treatment of Cutaneous T-cell LymphomaCompletedNCT00431912Phase 2
- Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid TumorsCompletedNCT00413322Phase 1
- Study of Oral PXD101 in Patients With Advanced Solid Tumors or LymphomaCompletedNCT00413075Phase 1
- Clinical Trial of PXD101 in Patients With Advanced Multiple MyelomaCompletedNCT00131261Phase 2
- Efficacy and Safety Study of Miconazole Lauriad to Treat Oropharyngeal Candidiasis in HIV PatientsCompletedNCT00390780Phase 3
- Phase 3 Clinical Study for the Treatment of Cold SoreCompletedNCT00769314Phase 3